Farther Finance Advisors’s Rigel Pharmaceuticals RIGL Stock Holding History

Farther Finance Advisors’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$48.4K	Buy	1,006 +109	+12%	+$4.73K	﹤0.01%	3451
2026 Q2	$35.1K	Buy	897 +145	+19%	+$4.47K	﹤0.01%	3533
2026 Q1	$20.7K	Sell	752 -20	-3%	-$672	﹤0.01%	3630
2025 Q4	$33.1K	Buy	772 +42	+6%	+$1.58K	﹤0.01%	3092
2025 Q3	$20.7K	Buy	730 +8	+1%	+$239	﹤0.01%	3021
2025 Q2	$13.5K	Buy	722 +27	+4%	+$512	﹤0.01%	2914
2025 Q1	$11.9K	Buy	695 +28	+4%	+$568	﹤0.01%	2654
2024 Q4	$11.2K	Hold	667	–	–	﹤0.01%	2341
2024 Q3	$10.8K	Buy	+667	New	+$7.84K	﹤0.01%	2334

Other funds holding RIGL

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Burney Company Reston, Virginia $3.66B AUM 27.59% 1-Year Est. Return

Venture Visionary Partners Sylvania, Ohio $3.82B AUM 21.33% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return

JWS

Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

GWM

GK Wealth Management Reno, Nevada $178M AUM 41.48% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

TCM

Triumph Capital Management Denver, Colorado $573M AUM 15.32% 1-Year Est. Return

Farther Finance Advisors's RIGL Position: Q3 2026 in Review

Farther Finance Advisors increased its Rigel Pharmaceuticals (RIGL) stake by 12% in Q3 2026, buying an estimated $4.73K and bringing the position to 1,006 shares worth $48.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3451.

Farther Finance Advisors first reported a position in RIGL in Q3 2024 and has held it in 9 quarters since. 13 funds tracked by Wall St. Rank hold RIGL as of Q3 2026.

Farther Finance Advisors held 1,006 shares of Rigel Pharmaceuticals worth $48.4K as of Q3 2026.
Farther Finance Advisors bought 109 Rigel Pharmaceuticals shares in Q3 2026, an estimated $4.73K.
Rigel Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #3451 holding.
Farther Finance Advisors first reported a position in Rigel Pharmaceuticals in Q3 2024 and has held it in 9 quarters since.
13 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.